Episode 19 of this series of the Mantell Associates Network welcomes David Enloe, President and CEO ofRecro.
David Enole has over two decades of executive leadership experience in biotechnology, clinical drug development, and GMP manufacturing. Before joining Recro, David served as President and Chief Executive Officer of Ajinomoto Bio-Pharma Services, a global, fully integrated CDMO.
In this episode, Alessandro speaks with David Enloe who shares the practices he has adopted in the past year to overcome challenges, discusses Recro’s vision and mission as a business, and shares his thoughts on the role of a successful CEO and the secrets to good leadership.
Recro are pioneering the development of modified release technology, enabling the growth of therapies that markedly improve patient quality of life. Their capabilities range from early feasibility and product development to commercial manufacturing and regulatory support for oral solid dosage forms. You can also listen to this podcast on the following streams.
The aim of the Mantell Associates Network Podcastis to connect people all around the world and empower people and businesses by sharing the stories, advice and outlook of influential leaders at market-leading companies across the industry. This podcasts provides exposure for the individuals and businesses currently doing great things, and works to unify the Pharmaceutical & Life Science industry.